We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Analysis of Microalbuminuria and Markers of Inflammation and Oxidative Stress in Adolescents of Different Ethnic Backgrounds (IM)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00616707
First Posted: February 15, 2008
Last Update Posted: May 30, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Children's Miracle Network
Information provided by (Responsible Party):
University of California, Davis
  Purpose
The purpose of this study is to determine if there are signs of inflammation in one's blood and urine and to find out if one's body size or ethnicity has an effect on these substances.

Condition
Inflammation

Study Type: Observational
Study Design: Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Analysis of Microalbuminuria and Markers of Inflammation and Oxidative Stress in Adolescents of Different Ethnic Backgrounds

Further study details as provided by University of California, Davis:

Primary Outcome Measures:
  • To compare plasma levels of inflammatory markers and urinary biomarkers of oxidative stress in adolescents of Hispanic, African-American and Caucasian ethnicity [ Time Frame: at the end of study ]

Secondary Outcome Measures:
  • To determine if there is an independent correlation between these markers and urinary microalbumin excretion [ Time Frame: at the end of study ]

Biospecimen Retention:   Samples Without DNA
Aliquots from the citrate vial & Serum seperator vial are being retained

Enrollment: 68
Study Start Date: August 2006
Study Completion Date: October 2009
Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
pediatric out-patient at UCDavis Medical Center clinic
Criteria

Inclusion Criteria:

  • Adolescents between 12 to 18 years old
  • Hispanic, African American or Caucasian ethnicity
  • Have a Body Mass Index (BMI) between the 5th and 85th percentile or greater than the 95th percentile
  • Must currently be attending a UC Davis Pediatric clinic

Exclusion Criteria:

  • Chronic liver or kidney disease, known Diabetes or other chronic illnesses (such as Sickle Cell Disease or Cystic Fibrosis)
  • Subjects can NOT be acutely febrile, smoke, chronically use prescription medications or oral contraceptive pills.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00616707


Locations
United States, California
UC Davis Medical Center
Sacramento, California, United States, 95817
Sponsors and Collaborators
University of California, Davis
Children's Miracle Network
Investigators
Principal Investigator: Lavjay Butani, M.D. University of California, Davis
  More Information

Responsible Party: University of California, Davis
ClinicalTrials.gov Identifier: NCT00616707     History of Changes
Other Study ID Numbers: 200614513
First Submitted: February 4, 2008
First Posted: February 15, 2008
Last Update Posted: May 30, 2017
Last Verified: May 2017

Keywords provided by University of California, Davis:
Inflammation
Oxidative Stress
Microalbuminuria

Additional relevant MeSH terms:
Inflammation
Pathologic Processes